These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 29551896)

  • 1. Targeted co-delivery of Beclin 1 siRNA and FTY720 to hepatocellular carcinoma by calcium phosphate nanoparticles for enhanced anticancer efficacy.
    Wu JY; Wang ZX; Zhang G; Lu X; Qiang GH; Hu W; Ji AL; Wu JH; Jiang CP
    Int J Nanomedicine; 2018; 13():1265-1280. PubMed ID: 29551896
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhancing anti-tumor efficiency in hepatocellular carcinoma through the autophagy inhibition by miR-375/sorafenib in lipid-coated calcium carbonate nanoparticles.
    Zhao P; Li M; Wang Y; Chen Y; He C; Zhang X; Yang T; Lu Y; You J; Lee RJ; Xiang G
    Acta Biomater; 2018 May; 72():248-255. PubMed ID: 29555460
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Turning an antiviral into an anticancer drug: nanoparticle delivery of acyclovir monophosphate.
    Yao J; Zhang Y; Ramishetti S; Wang Y; Huang L
    J Control Release; 2013 Sep; 170(3):414-20. PubMed ID: 23791977
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Galactose Derivative-Modified Nanoparticles for Efficient siRNA Delivery to Hepatocellular Carcinoma.
    Huang KW; Lai YT; Chern GJ; Huang SF; Tsai CL; Sung YC; Chiang CC; Hwang PB; Ho TL; Huang RL; Shiue TY; Chen Y; Wang SK
    Biomacromolecules; 2018 Jun; 19(6):2330-2339. PubMed ID: 29808997
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Calcium phosphate nanoparticles with an asymmetric lipid bilayer coating for siRNA delivery to the tumor.
    Li J; Yang Y; Huang L
    J Control Release; 2012 Feb; 158(1):108-14. PubMed ID: 22056915
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Co-delivery of camptothecin and MiR-145 by lipid nanoparticles for MRI-visible targeted therapy of hepatocellular carcinoma.
    Rong J; Liu T; Yin X; Shao M; Zhu K; Li B; Wang S; Zhu Y; Zhang S; Yin L; Liu Q; Wang X; Zhang L
    J Exp Clin Cancer Res; 2024 Aug; 43(1):247. PubMed ID: 39215325
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Co-delivery of sorafenib and metapristone encapsulated by CXCR4-targeted PLGA-PEG nanoparticles overcomes hepatocellular carcinoma resistance to sorafenib.
    Zheng N; Liu W; Li B; Nie H; Liu J; Cheng Y; Wang J; Dong H; Jia L
    J Exp Clin Cancer Res; 2019 May; 38(1):232. PubMed ID: 31151472
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combination treatment of FTY720 and cisplatin exhibits enhanced antitumour effects on cisplatin-resistant non-small lung cancer cells.
    Li Y; Hu T; Chen T; Yang T; Ren H; Chen M
    Oncol Rep; 2018 Feb; 39(2):565-572. PubMed ID: 29207165
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhanced delivery of siRNA to triple negative breast cancer cells in vitro and in vivo through functionalizing lipid-coated calcium phosphate nanoparticles with dual target ligands.
    Tang J; Howard CB; Mahler SM; Thurecht KJ; Huang L; Xu ZP
    Nanoscale; 2018 Mar; 10(9):4258-4266. PubMed ID: 29436549
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Effect of and Mechanism Underlying Autophagy in Hepatocellular Carcinoma Induced by CH12, a Monoclonal Antibody Directed Against Epidermal Growth Factor Receptor Variant III.
    Xu W; Song F; Wang B; Li K; Tian M; Yu M; Pan X; Shi B; Liu J; Gu J; Li Z; Jiang H
    Cell Physiol Biochem; 2018; 46(1):226-237. PubMed ID: 29587298
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Systemic delivery of siRNA by hyaluronan-functionalized calcium phosphate nanoparticles for tumor-targeted therapy.
    Qiu C; Wei W; Sun J; Zhang HT; Ding JS; Wang JC; Zhang Q
    Nanoscale; 2016 Jul; 8(26):13033-44. PubMed ID: 27314204
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antitumor effects of OSU-2S, a nonimmunosuppressive analogue of FTY720, in hepatocellular carcinoma.
    Omar HA; Chou CC; Berman-Booty LD; Ma Y; Hung JH; Wang D; Kogure T; Patel T; Terracciano L; Muthusamy N; Byrd JC; Kulp SK; Chen CS
    Hepatology; 2011 Jun; 53(6):1943-58. PubMed ID: 21391227
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Knockdown of eukaryotic translation initiation factor 5A2 enhances the therapeutic efficiency of doxorubicin in hepatocellular carcinoma cells by triggering lethal autophagy.
    Tang Y; Chen K; Luan X; Zhang J; Liu R; Zheng X; Xie S; Ke H; Zhang X; Chen W
    Int J Oncol; 2020 Dec; 57(6):1368-1380. PubMed ID: 33174013
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synergism of cisplatin-oleanolic acid co-loaded calcium carbonate nanoparticles on hepatocellular carcinoma cells for enhanced apoptosis and reduced hepatotoxicity.
    Khan MW; Zhao P; Khan A; Raza F; Raza SM; Sarfraz M; Chen Y; Li M; Yang T; Ma X; Xiang G
    Int J Nanomedicine; 2019; 14():3753-3771. PubMed ID: 31239661
    [No Abstract]   [Full Text] [Related]  

  • 15. PEGylated carboxymethyl chitosan/calcium phosphate hybrid anionic nanoparticles mediated hTERT siRNA delivery for anticancer therapy.
    Xie Y; Qiao H; Su Z; Chen M; Ping Q; Sun M
    Biomaterials; 2014 Sep; 35(27):7978-91. PubMed ID: 24939077
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lipid-modified cell-penetrating peptide-based self-assembly micelles for co-delivery of narciclasine and siULK1 in hepatocellular carcinoma therapy.
    Wang X; Wu F; Li G; Zhang N; Song X; Zheng Y; Gong C; Han B; He G
    Acta Biomater; 2018 Jul; 74():414-429. PubMed ID: 29787814
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New FTY720-docetaxel nanoparticle therapy overcomes FTY720-induced lymphopenia and inhibits metastatic breast tumour growth.
    Alshaker H; Wang Q; Srivats S; Chao Y; Cooper C; Pchejetski D
    Breast Cancer Res Treat; 2017 Oct; 165(3):531-543. PubMed ID: 28695300
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhancing Targeted Therapy in Hepatocellular Carcinoma through a pH-Responsive Delivery System: Folic Acid-Modified Polydopamine-Paclitaxel-Loaded Poly(3-hydroxybutyrate-
    Wu M; Wang Q; Peng Y; Liang X; Lv X; Wang S; Zhong C
    Mol Pharm; 2024 Feb; 21(2):581-595. PubMed ID: 38131328
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization and Cytotoxicity of Polyprenol Lipid and Vitamin E-TPGS Hybrid Nanoparticles for Betulinic Acid and Low-Substituted Hydroxyl Fullerenol in MHCC97H and L02 Cells.
    Tao R; Wang C; Lu Y; Zhang C; Zhou H; Chen H; Li W
    Int J Nanomedicine; 2020; 15():2733-2749. PubMed ID: 32368052
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selenium nanoparticles coated with pH responsive silk fibroin complex for fingolimod release and enhanced targeting in thyroid cancer.
    Zou X; Jiang Z; Li L; Huang Z
    Artif Cells Nanomed Biotechnol; 2021 Dec; 49(1):83-95. PubMed ID: 33438446
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.